Reference
Government of Canada. DARZALEX (daratumumab) and Hepatitis B Virus Reactivation. Internet Document : 25 Mar 2019. Available from: URL: https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/69402a-eng.php
Rights and permissions
About this article
Cite this article
Daratumumab linked with HBV reactivation, some fatalities. Reactions Weekly 1747, 1 (2019). https://doi.org/10.1007/s40278-019-59642-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-59642-3